Prostate cancer patients see longer survival with new combination drug
PositiveU.S News

A recent study from UCLA reveals that a new combination treatment, which pairs a radioactive drug with radiation therapy, significantly benefits men with recurring prostate cancer. This innovative approach not only improves survival rates but also delays the need for hormone therapy, offering hope to patients facing this challenging diagnosis. Such advancements in cancer treatment are crucial as they can lead to better quality of life and extended time with loved ones.
— Curated by the World Pulse Now AI Editorial System